Stephen Liu, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Dr. Solange Peters at ITCD2025 gives a masterful talk on the next generation of checkpoint inhibitors and how novel agents hope to overcome and prevent immune resistance.”
More posts featuring Stephen Liu.
